ArticleMicrobial biotechnology2026
Recent Advances in the Molecular Mechanisms of Bacterial Anti-Phage Defence Systems.
Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning models based on both distant protein sequence homology and genetic neighbourhood context searches predicted that 1.5% of bacterial genes or 30 genes per E. coli genome represent anti-phage systems (APS); many are colocalized on defence islands or are found on mobile DNA elements. Thousands of APS thus remain to be defined molecularly. Selected recent examples highlighting an astonishing molecular diversity of these defence systems are described in this editorial. The mechanisms include allosterically regulated dGTPase responding to competing nucleotide signals (Clover); bacterial defence systems activated by phage anti-defence manoeuvres (Panoptes); a prophage encoded tRNA nuclease activated by a phage tail tip protein (HepS); a helicase-nuclease complex that scans for ssDNA 3' overhangs created by phage DNA transaction (Hachiman); and systems that cleave free ends of linear DNA (Shedu). Systems were described that synthesize template-free poly-dA chains which are degraded by a phage exonuclease thereby activating an ion channel (Hailong). Several systems interfere with phage DNA injection into the cell, for example, a cell membrane associated protein complex inhibiting injection (KIWA); or destroying phage DNA at injection (SNIPE); or a complex membrane motor system that senses phage DNA injection and activates nuclease effectors (Zorya). Other systems consist of a single pore building protein that combines sensor and effector functions (Rip1) or degrade NAD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.